Cargando…

Coexpression analysis of CD133 and CD44 identifies Proneural and Mesenchymal subtypes of glioblastoma multiforme

Accumulating evidence suggests that the stem cell markers CD133 and CD44 indicate molecular subtype in Glioblastoma Multiforme (GBM). Gene coexpression analysis of The Cancer Genome Atlas GBM dataset was undertaken to compare markers of the Glioblastoma Stem-Progenitor Cell (GSPC) phenotype. Pearson...

Descripción completa

Detalles Bibliográficos
Autores principales:	Brown, Daniel V., Daniel, Paul M., D'Abaco, Giovanna M., Gogos, Andrew, Ng, Wayne, Morokoff, Andrew P., Mantamadiotis, Theo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2015
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4467436/ https://www.ncbi.nlm.nih.gov/pubmed/25749043

Ejemplares similares

Expression of CD133 and CD44 in glioblastoma stem cells correlates with cell proliferation, phenotype stability and intra-tumor heterogeneity
por: Brown, Daniel V., et al.
Publicado: (2017)

CD133 Expression in Glioblastoma Multiforme: A Literature Review
por: Ahmed, Syed Ijlal, et al.
Publicado: (2018)

Prominin 1/CD133 Endothelium Sustains Growth of Proneural Glioma
por: Ding, Bi-Sen, et al.
Publicado: (2013)

Impact of CD133 positive stem cell proportion on survival in patients with glioblastoma multiforme
por: Kase, Marju, et al.
Publicado: (2013)

Altered cytoskeletal status in the transition from proneural to mesenchymal glioblastoma subtypes
por: Keller, Maureen, et al.
Publicado: (2022)

Impairing proliferation of glioblastoma multiforme with CD44+ selective conjugated polymer nanoparticles
por: Lubanska, Dorota, et al.
Publicado: (2022)

Sensitivity of GBM cells to cAMP agonist-mediated apoptosis correlates with CD44 expression and agonist resistance with MAPK signaling
por: Daniel, Paul M, et al.
Publicado: (2016)

Coexpression of CD44-positive/CD133-positive cancer stem cells and CD204-positive tumor-associated macrophages is a predictor of survival in pancreatic ductal adenocarcinoma
por: Hou, Ya-Chin, et al.
Publicado: (2014)

Higher vascularity at infiltrated peripheral edema differentiates proneural glioblastoma subtype
por: Chelebian, Eduard, et al.
Publicado: (2020)

Angiogenin Upregulation Independently Predicts Unfavorable Overall Survival in Proneural Subtype of Glioblastoma
por: Hu, Ji-liang, et al.
Publicado: (2019)

CDK4/6 inhibition is more active against the glioblastoma proneural subtype
por: Li, Ming, et al.
Publicado: (2017)

Mesenchymal and Proneural Subtypes of Glioblastoma Disclose Branching Based on GSC Associated Signature
por: Steponaitis, Giedrius, et al.
Publicado: (2021)

Inhibition of Radiation and Temozolomide-Induced Glioblastoma Invadopodia Activity Using Ion Channel Drugs
por: Dinevska, Marija, et al.
Publicado: (2020)

The Potential Role of CD44 and CD133 in Colorectal Stem Cell Cancer
por: Abdou Hassan, Wael, et al.
Publicado: (2022)

Cancer Stem Cell Markers CD44, CD133 in Primary Gastric Adenocarcinoma
por: Nosrati, Anahita, et al.
Publicado: (2014)

Evaluation of CD44 and CD133 as cancer stem cell markers for colorectal cancer
por: WANG, CHUNXIA, et al.
Publicado: (2012)

Clinicopathological significance of CD133 and CD44 expression in infiltrating ductal carcinoma and their relationship to angiogenesis
por: Han, Zhengquan, et al.
Publicado: (2015)

CD44/CD133-Positive Colorectal Cancer Stem Cells are Sensitive to Trifluridine Exposure
por: Tsunekuni, Kenta, et al.
Publicado: (2019)

Cobalt ferrite nanoparticle for the elimination of CD133+CD44(+) and CD44(+)CD24(−), in breast and skin cancer stem cells, using non-ionizing treatments
por: Khalili Najafabad, Bahareh, et al.
Publicado: (2023)

Prognostic value of CD133(+) CD54(+) CD44(+) circulating tumor cells in colorectal cancer with liver metastasis
por: Fang, Chao, et al.
Publicado: (2017)

Role of CD44(high)/CD133(high) HCT-116 cells in the tumorigenesis of colon cancer
por: Zhou, Jin-Yong, et al.
Publicado: (2016)

Investigating the Link between Molecular Subtypes of Glioblastoma, Epithelial-Mesenchymal Transition, and CD133 Cell Surface Protein
por: Zarkoob, Hadi, et al.
Publicado: (2013)

Angiogenic Gene Signature Derived from Subtype Specific Cell Models Segregate Proneural and Mesenchymal Glioblastoma
por: Sharma, Aman, et al.
Publicado: (2017)

Increased LGALS3 expression independently predicts shorter overall survival in patients with the proneural subtype of glioblastoma
por: He, Xia, et al.
Publicado: (2019)

Selective CREB-dependent cyclin expression mediated by the PI3K and MAPK pathways supports glioma cell proliferation
por: Daniel, P, et al.
Publicado: (2014)

Dihydropyrimidinase-related protein 5 controls glioblastoma stem cell characteristics as a biomarker of proneural-subtype glioblastoma stem cells
por: Park, Min Gi, et al.
Publicado: (2020)

Coexpression of EpCAM, CD44 Variant Isoforms and Claudin-7 in Anaplastic Thyroid Carcinoma
por: Okada, Toshihiro, et al.
Publicado: (2014)

Gliomasphere marker combinatorics: multidimensional flow cytometry detects CD44+/CD133+/ITGA6+/CD36+ signature
por: Erhart, Friedrich, et al.
Publicado: (2018)

Repurposing FDA-approved drugs as inhibitors of therapy-induced invadopodia activity in glioblastoma cells
por: Jones, Dylan, et al.
Publicado: (2022)

Expression of the Cancer Stem Cell Markers CD44 and CD133 in Colorectal Cancer: An Immunohistochemical Staining Analysis
por: Hong, Injae, et al.
Publicado: (2015)

PATZ1 is a new prognostic marker of glioblastoma associated with the stem-like phenotype and enriched in the proneural subtype
por: Guadagno, Elia, et al.
Publicado: (2017)

Brca1 breast tumors contain distinct CD44(+)/CD24(- )and CD133(+ )cells with cancer stem cell characteristics
por: Wright, Mollie H, et al.
Publicado: (2008)

ME2 Promotes Proneural–Mesenchymal Transition and Lipogenesis in Glioblastoma
por: Yang, Mengting, et al.
Publicado: (2021)

Immunohistochemical Detection of Cancer Stem Cell Related Markers CD44 and CD133 in Metastatic Colorectal Cancer Patients
por: Pitule, Pavel, et al.
Publicado: (2014)

Effects of flavopiridol on critical regulation pathways of CD133(high)/CD44(high) lung cancer stem cells
por: Bozok Cetintas, Vildan, et al.
Publicado: (2016)

CD133(+)CD54(+)CD44(+) circulating tumor cells as a biomarker of treatment selection and liver metastasis in patients with colorectal cancer
por: Fang, Chao, et al.
Publicado: (2016)

Expression and Clinical Significance of Cancer Stem Cell Markers CD24, CD44, and CD133 in Pancreatic Ductal Adenocarcinoma and Chronic Pancreatitis
por: Durko, L., et al.
Publicado: (2017)

The proneural subtype is not associated with survival benefit from bevacizumab in newly diagnosed glioblastoma: a secondary analysis of the GLARIUS trial
por: Weller, Johannes, et al.
Publicado: (2023)

Analysis of gene expression and chemoresistance of CD133(+ )cancer stem cells in glioblastoma
por: Liu, Gentao, et al.
Publicado: (2006)

Mesenchymal stem cell-like properties of CD133(+) glioblastoma initiating cells
por: Pavon, Lorena Favaro, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_1om6je41fj2ns17riu3g0nu12f